Medical Policy and Coding Updates - November 2022
Summary
Botulinum toxin codes J0585, J0586, J0587 and J0588 require review for medical necessity and prior authorization for dates of service starting on and after December 1, 2022, under the temporomandibular joint disorder and hyperhidrosis policies. Other changes revised criteria for genetic testing, Spravato, transcranial magnetic stimulation and gender transition surgery, and total ankle replacement (27703) no longer requires review.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.